Injectable hydrogel with MSNs/microRNA-21-5p delivery enables both immunomodification and enhanced angiogenesis for myocardial infarction therapy in pigs

Current therapeutic strategies such as angiogenic therapy and anti-inflammatory therapy for treating myocardial infarction have limited success. An effective approach may benefit from resolution of excessive inflammation combined with enhancement of angiogenesis. Here, we developed a microRNA-21-5p...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yan, Chen, Xin, Jin, Ronghua, Chen, Lu, Dang, Ming, Cao, Hao, Dong, Yun, Cai, Bolei, Bai, Guo, Gooding, J. Justin, Liu, Shiyu, Zou, Duohong, Zhang, Zhiyuan, Yang, Chi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904259/
https://www.ncbi.nlm.nih.gov/pubmed/33627421
http://dx.doi.org/10.1126/sciadv.abd6740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7904259/
https://www.ncbi.nlm.nih.gov/pubmed/33627421
http://dx.doi.org/10.1126/sciadv.abd6740

Ejemplares similares